- Home
- BAX vs ARE Comparison
BAX vs ARE Comparison
Compare BAX & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAX | ARE |
|---|---|---|
| Founded | 1931 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.1B |
| IPO Year | 1994 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BAX | ARE |
|---|---|---|
| Price | $17.91 | $51.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 11 |
| Target Price | $22.38 | ★ $58.78 |
| AVG Volume (30 Days) | ★ 9.4M | 1.8M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | 0.23% | ★ 9.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,244,000,000.00 | $3,026,556,000.00 |
| Revenue This Year | $1.90 | N/A |
| Revenue Next Year | $2.09 | $0.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.72 | N/A |
| 52 Week Low | $17.40 | $44.10 |
| 52 Week High | $36.57 | $102.73 |
Technical Indicators
Market Signals| Indicator | BAX | ARE |
|---|---|---|
| Relative Strength Index (RSI) | 34.45 | 41.36 |
| Support Level | $17.69 | $49.38 |
| Resistance Level | $19.31 | $54.86 |
| Average True Range (ATR) | 0.78 | 1.77 |
| MACD | -0.38 | -0.34 |
| Stochastic Oscillator | 16.75 | 38.80 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.